Breast Cancer News

Patient withdrawal from cancer clinical trials can result in systematic bias, insufficiently powered studies and a loss of valuable scientific knowledge, according to a study in JAMA Network Open.

Women aged 69 years who underwent surgery for high-risk breast cancer received recommendations for adjuvant radiation therapy nearly two times more often than women a year older undergoing the same procedure, study results showed.

In this video, Paolo Tarantino, MD, discusses findings from DESTINY-Breast 04 presented at San Antonio Breast Cancer Symposium.

In this video, Paolo Tarantino, MD, discusses findings from the EMERALD phase 3 trial presented at San Antonio Breast Cancer Symposium.

The FDA approved elacestrant for certain patients with advanced or metastatic breast cancer.

Liquid biopsy effectively predicted survival outcomes among a cohort of patients with various metastatic cancer types, according to study results published in Annals of Oncology.

New technology that identifies which populations of breast cancer cells are likely to drive invasion and metastasis has revealed that the location of cancer cells may be as essential to tumor growth as mutations.

Cancer burden among older adults with type 2 diabetes has increased in the past 2 decades while all-cause mortality rates at all ages have decreased, according to a 20-year population-based study published in Diabetologia.

Nearly 3 years after the COVID-19 pandemic propelled telehealth from the fringes of cancer care to the mainstream, research into the use of this technology across oncology remains limited.

Black women who smoked at the time of breast cancer diagnosis had a 52% increased risk for all-cause mortality compared with Black women who never smoked, according to study results published in JAMA Network Open.